当前位置:首页 - 行情中心 - 益丰药房(603939) - 财务分析 - 现金流量表

益丰药房

(603939)

  

流通市值:244.90亿  总市值:244.90亿
流通股本:12.12亿   总股本:12.12亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金6,624,771,668.3226,023,017,132.7719,024,372,147.8712,970,362,874.41
  收到其他与经营活动有关的现金388,569,566.23280,538,285.28324,699,961.01292,322,002.08
  经营活动现金流入小计7,013,341,234.5526,303,555,418.0519,349,072,108.8813,262,684,876.49
  购买商品、接受劳务支付的现金4,146,033,290.8516,142,039,574.3312,039,371,038.98,342,308,188.84
  支付给职工以及为职工支付的现金1,178,161,512.063,913,340,631.953,015,007,149.62,069,087,898.96
  支付的各项税费332,149,890.981,363,148,902.841,035,250,760.61720,530,230.58
  支付其他与经营活动有关的现金300,625,302.551,526,578,294.52992,232,141.96561,092,769.92
  经营活动现金流出小计5,956,969,996.4422,945,107,403.6417,081,861,091.0711,693,019,088.3
  经营活动产生的现金流量净额1,056,371,238.113,358,448,014.412,267,211,017.811,569,665,788.19
二、投资活动产生的现金流量:
  收回投资收到的现金-432,639,550.39432,639,550.39-
  取得投资收益收到的现金-13,029,683.1812,813,00012,813,000
  处置固定资产、无形资产和其他长期资产收回的现金净额1,378,629.4624,180,412.21,562,120.081,130,146.66
  处置子公司及其他营业单位收到的现金净额-1,200,0001,200,000-
  收到的其他与投资活动有关的现金5,119,787,658.5223,780,824,318.1222,169,996,726.0315,323,272,808.13
  投资活动现金流入小计5,121,166,287.9824,251,873,963.8922,618,211,396.515,337,215,954.79
  购建固定资产、无形资产和其他长期资产支付的现金13,692,017.78322,916,673.8108,169,339.7263,360,568.89
  投资支付的现金500,000---
  取得子公司及其他营业单位支付的现金2,878,000136,624,098.96120,448,134.62105,199,954.08
  支付其他与投资活动有关的现金5,410,000,00025,218,512,080.0522,752,770,00015,384,600,000
  投资活动现金流出小计5,427,070,017.7825,678,052,852.8122,981,387,474.3415,553,160,522.97
  投资活动产生的现金流量净额-305,903,729.8-1,426,178,888.92-363,176,077.84-215,944,568.18
三、筹资活动产生的现金流量:
  吸收投资收到的现金-1,762,8001,753,0001,753,000
  其中:子公司吸收少数股东投资收到的现金-1,762,8001,753,0001,753,000
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-1,762,8001,753,0001,753,000
  偿还债务支付的现金-91,429,093.471,429,093.461,429,093.4
  分配股利、利润或偿付利息支付的现金19,029,494.19927,168,979.77914,684,834.87494,902,456.92
  其中:子公司支付给少数股东的股利、利润10,042,829.8877,862,107.1859,810,385.754,179,101.78
  支付其他与筹资活动有关的现金309,327,559.791,462,963,278.611,091,414,192.98740,812,474.92
  筹资活动现金流出小计328,357,053.982,481,561,351.782,077,528,121.251,297,144,025.24
  筹资活动产生的现金流量净额-328,357,053.98-2,479,798,551.78-2,075,775,121.25-1,295,391,025.24
五、现金及现金等价物净增加额422,110,454.33-547,529,426.29-171,740,181.2858,330,194.77
  加:期初现金及现金等价物余额1,613,268,444.232,160,797,870.522,160,797,870.522,160,797,870.52
  期末现金及现金等价物余额2,035,378,898.561,613,268,444.231,989,057,689.242,219,128,065.29
补充资料:
  净利润-1,831,025,556.6-945,793,936.37
  资产减值准备-111,612,199.85-46,492,233.84
  固定资产和投资性房地产折旧-251,570,236.59-119,655,431
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-251,570,236.59-119,655,431
  无形资产摊销-35,447,455.59-17,726,568.46
  长期待摊费用摊销-213,679,615.32-107,007,981.24
  处置固定资产、无形资产和其他长期资产的损失--68,481,322.52--33,874,543.07
  固定资产报废损失-3,017,429.25-1,036,265.72
  财务费用-149,749,475.13-101,032,831.38
  投资损失--124,747,936.19--69,308,547.03
  递延所得税--904,087.33-4,914,715.32
  其中:递延所得税资产减少-3,155,013.72-6,944,265.85
    递延所得税负债增加--4,059,101.05--2,029,550.53
  存货的减少--206,446,787.59-292,970,637.87
  经营性应收项目的减少-169,264,402.32-1,051,733,287.64
  经营性应付项目的增加--447,323,731.63--1,749,881,096.93
  其他--21,777,808.7-824,451.76
  现金的期末余额-1,613,268,444.23-2,219,128,065.29
  减:现金的期初余额-2,160,797,870.52-2,160,797,870.52
  现金及现金等价物的净增加额--547,529,426.29-58,330,194.77
公告日期2026-04-232026-04-232025-10-302025-08-29
审计意见(境内)标准无保留意见
TOP↑